Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5